Tokyo, Japan

Tsukasa Matsumoto

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Kao Corporation, Other. Active years: 1992-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tsukasa Matsumoto. Retrieved from https://idiyas.com/inventor/tsukasa-matsumoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 1.4

ph-index = 1


Location History:

  • Tokyo 143, JP (2001)
  • Tokyo, JP (1992 - 2004)

Company Filing History:


Years Active: 1992-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tsukasa Matsumoto: Innovator in Blood Component Technologies

Introduction

Tsukasa Matsumoto is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical technology, particularly in the area of blood component extraction and fractionation. With a total of 3 patents to his name, Matsumoto's work has the potential to impact therapeutic practices significantly.

Latest Patents

Matsumoto's latest patents include innovative methods for obtaining and fractionating blood components. One of his notable inventions is a method for obtaining components from cultured leucocytes. This method involves a two-step process: first, fracturing the cell membrane of leucocytes using various techniques such as freezing and defrosting, and second, separating and collecting the leucocyte components through centrifugal precipitation or electrophoresis techniques. These components are then subjected to therapeutic tests to evaluate their effects on patients with various diseases.

Another significant patent is a method for fractionating red blood cells and producing antibacterial materials. This method involves mixing a human blood sample with a dextran aqueous solution to create three distinct layers. Each layer is then separated and treated to produce antibacterial or bacterial proliferation inhibitory materials. This innovative approach allows for the easy fractionation of blood components, which can be utilized in various clinical tests.

Career Highlights

Throughout his career, Matsumoto has worked with notable companies, including Kao Corporation. His experience in these organizations has contributed to his expertise in medical technology and innovation.

Collaborations

Matsumoto has collaborated with esteemed colleagues such as Kazuya Otsuji and Hakaru Inaoka. These partnerships have likely enhanced his research and development efforts in the field of blood component technologies.

Conclusion

Tsukasa Matsumoto is a distinguished inventor whose work in blood component extraction and fractionation holds promise for advancing medical treatments. His innovative patents reflect a commitment to improving therapeutic practices and enhancing patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…